Literature DB >> 8971348

Effects of retinoic acid on Xenopus embryos.

R W Old1, D P Smith, C S Mason, S Marklew, E A Jones.   

Abstract

Retinoic acid (RA) has powerful dose-dependent dysmorphogenic effects on Xenopus embryos. The defects produced are dependent upon the stage and duration of treatment. Characteristic dysmorphogenic effects occur in the visceral (branchial) arch region and the tail. These regions correspond to the domains of expression of the retinoid receptors RAR gamma and RXR beta. By expressing domain-swapped and dominant negative derivatives of RAR gamma in embryos, we have shown that the effects of RA are mediated transcriptionally. Furthermore, the expression of dominant negative receptors in the absence of exogenous ligand has no apparent harmful effect upon early development. Finally, we have identified a novel MAP kinase phosphatase whose expression pattern is localized to regions similar to RAR gamma, and which is upregulated by RA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971348

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  3 in total

1.  Expression of interferon regulatory factor-1 in the mouse cumulus-oocyte complex is negatively related with oocyte maturation.

Authors:  Yun-Sun Kim; Eun-Young Kim; Jisook Moon; Tae-Ki Yoon; Woo-Sik Lee; Kyung-Ah Lee
Journal:  Clin Exp Reprod Med       Date:  2011-12-31

2.  Retinoic Acid Protects and Rescues the Development of Zebrafish Embryonic Retinal Photoreceptor Cells from Exposure to Paclobutrazol.

Authors:  Wen-Der Wang; Hwei-Jan Hsu; Yi-Fang Li; Chang-Yi Wu
Journal:  Int J Mol Sci       Date:  2017-01-11       Impact factor: 5.923

Review 3.  The Usefulness of Retinoic Acid Supplementation during In Vitro Oocyte Maturation for the In Vitro Embryo Production of Livestock: A Review.

Authors:  Sameh A Abdelnour; Mohamed E Abd El-Hack; Ayman Abdel-Aziz Swelum; Islam M Saadeldin; Ahmed E Noreldin; Asmaa F Khafaga; Mohsen G Al-Mutary; Muhammad Arif; El-Sayed O S Hussein
Journal:  Animals (Basel)       Date:  2019-08-15       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.